Comment on "Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".
作者信息
Kuss Oliver, Rathmann Wolfgang
机构信息
German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Institute for Biometrics and Epidemiology, Düsseldorf, Germany.
Centre for Health and Society, Faculty of Medicine, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
出版信息
Drug Saf. 2023 May;46(5):509-512. doi: 10.1007/s40264-023-01292-6. Epub 2023 Apr 15.
Abstract
摘要
相似文献
1
Comment on "Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".关于《钠-葡萄糖协同转运蛋白2抑制剂与他汀类药物的药物相互作用及肌病：使用不良事件报告数据的不成比例性分析》的评论
Drug Saf. 2023 May;46(5):509-512. doi: 10.1007/s40264-023-01292-6. Epub 2023 Apr 15.
2
Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".关于《钠-葡萄糖协同转运蛋白2抑制剂与他汀类药物的药物相互作用及肌病：使用不良事件报告数据的不成比例性分析》的评论
Drug Saf. 2022 Jul;45(7):809-811. doi: 10.1007/s40264-022-01191-2. Epub 2022 Jun 17.
3
Authors' Reply to Noguchi's comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.".作者对野口对《钠-葡萄糖协同转运蛋白2抑制剂与他汀类药物的药物相互作用及肌病：使用不良事件报告数据的不成比例性分析》的评论的回复。
Drug Saf. 2022 Jul;45(7):813-814. doi: 10.1007/s40264-022-01192-1. Epub 2022 Jun 17.
4
Author's Reply to Kuss and Rathmann's Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".作者对库斯和拉特曼就《钠-葡萄糖协同转运蛋白2抑制剂与他汀类药物的药物相互作用及肌病：使用不良事件报告数据的不成比例性分析》的评论的回复
Drug Saf. 2023 May;46(5):513-514. doi: 10.1007/s40264-023-01293-5. Epub 2023 Apr 15.
5
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.钠-葡萄糖协同转运蛋白 2 抑制剂与他汀类药物和肌病的药物-药物相互作用：使用不良反应报告数据的比例失调分析。
Drug Saf. 2022 Mar;45(3):287-295. doi: 10.1007/s40264-022-01166-3. Epub 2022 Mar 5.
6
Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis.同时使用他汀类药物和钠-葡萄糖共转运蛋白 2 抑制剂与肌毒性报告风险：一项比例失调分析。
Br J Clin Pharmacol. 2023 Aug;89(8):2430-2445. doi: 10.1111/bcp.15711. Epub 2023 Mar 28.
7
Myopathy Associated With Statins and SGLT2 - A Review of Literature.他汀类药物和 SGLT2 相关肌病：文献综述。
Curr Probl Cardiol. 2021 Apr;46(4):100765. doi: 10.1016/j.cpcardiol.2020.100765. Epub 2020 Dec 11.
8
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system.真实世界中 DPP-4 抑制剂与他汀类药物相关肌病：通过 FDA 不良事件报告系统研究药物相互作用的可能性。
Acta Diabetol. 2020 Jan;57(1):71-80. doi: 10.1007/s00592-019-01378-7. Epub 2019 Jun 15.
9
Potential drug-drug interaction between sodium-glucose co-transporter 2 inhibitors and statins: pharmacological and clinical evidence.钠-葡萄糖共转运蛋白 2 抑制剂与他汀类药物之间的潜在药物相互作用：药理学和临床证据。
Expert Opin Drug Metab Toxicol. 2021 Jun;17(6):697-705. doi: 10.1080/17425255.2021.1921735. Epub 2021 May 26.
10
Statin induced myopathy. Use of statins with ciclosporin.他汀类药物引起的肌病。他汀类药物与环孢素的联合使用。
BMJ. 2008 Dec 2;337:a2788. doi: 10.1136/bmj.a2788.
本文引用的文献
1
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.钠-葡萄糖协同转运蛋白 2 抑制剂与他汀类药物和肌病的药物-药物相互作用：使用不良反应报告数据的比例失调分析。
Drug Saf. 2022 Mar;45(3):287-295. doi: 10.1007/s40264-022-01166-3. Epub 2022 Mar 5.
2
A missed protective drug-drug interaction of DPP-4 inhibitors and statins on myopathy risk.二肽基肽酶-4抑制剂与他汀类药物之间关于肌病风险的保护性药物相互作用被漏检。
Acta Diabetol. 2020 Jan;57(1):113-114. doi: 10.1007/s00592-019-01440-4. Epub 2019 Nov 6.
3
Statin-associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany.他汀类药物相关肌病。基于德国所有法定健康保险基金的数据评估其频率。
Pharmacol Res Perspect. 2018 May 10;6(3):e00404. doi: 10.1002/prp2.404. eCollection 2018 Jun.
4
Detecting signals of drug-drug interactions in a spontaneous reports database.在自发报告数据库中检测药物相互作用信号。
Br J Clin Pharmacol. 2007 Oct;64(4):489-95. doi: 10.1111/j.1365-2125.2007.02900.x. Epub 2007 May 15.
Zotero 插件